194 related articles for article (PubMed ID: 25803305)
1. APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.
Krell-Roesch J; Woodruff BK; Acosta JI; Locke DE; Hentz JG; Stonnington CM; Stokin GB; Nagle C; Michel BF; Sambuchi N; Caselli RJ; Geda YE
J Neuropsychiatry Clin Neurosci; 2015; 27(4):322-5. PubMed ID: 25803305
[TBL] [Abstract][Full Text] [Related]
2. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
3. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
6. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
[TBL] [Abstract][Full Text] [Related]
8. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
9. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.
Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S
J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936
[TBL] [Abstract][Full Text] [Related]
10. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
[TBL] [Abstract][Full Text] [Related]
11. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
14. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G
Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807
[TBL] [Abstract][Full Text] [Related]
16. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
17. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
18. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4.
Kutner KC; Erlanger DM; Tsai J; Jordan B; Relkin NR
Neurosurgery; 2000 Sep; 47(3):651-7; discussion 657-8. PubMed ID: 10981753
[TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
[TBL] [Abstract][Full Text] [Related]
20. Association of
GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]